Law
Offices of Howard G. Smith announces that a class action lawsuit has
been filed in the United States District Court for the District of
Massachusetts on behalf of purchasers of the securities of InVivo
Therapeutics Holdings Corp. (“InVivo” or the “Company”) (OTC:NVIV)
between April 5, 2013 and August 26, 2013, inclusive (the “Class
Period”).
InVivo develops biomaterial technologies for the treatment of spinal
cord injuries and hydrogels for therapeutics delivery. The Complaint
alleges that defendants misrepresented and/or failed to disclose that
the Company’s clinical study for its biopolymer scaffolding to treat
acute spinal cord injuries would not be completed with all data
submitted to the FDA by the end of 2014, and the Company did not
anticipate completing this clinical study until late 2015. As a result,
the Company’s statements about its clinical study timeline for
biopolymer scaffolding to treat acute spinal cord injuries were
materially false and misleading and/or lacked a reasonable basis.
If you are a member of the Class described above, you have until October
6, 2014, to move the Court to serve as lead plaintiff, if you meet
certain legal requirements. To be a member of the Class you need not
take any action at this time; you may retain counsel of your choice or
take no action and remain an absent member of the Class. If you wish to
learn more about this action, or if you have any questions concerning
this announcement or your rights or interests with respect to these
matters, please contact Howard G. Smith, Esquire, of Law Offices of
Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania
19020 by telephone at 215-638-4847, Toll-Free at 888-638-4847, or by
email to howardsmith@howardsmithlaw.com,
or visit our website at http://www.howardsmithlaw.com.
Copyright Business Wire 2014